{"groups":[{"description":"Radiation: CyberKnife Stereotactic Radiosurgery boost (2 fractionated doses) beginning 4-8 weeks after completion of standard therapy.\n\nstereotactic radiosurgery: Given in 2 fractionated doses or 5 fractionated doses","id":"FG000","title":"Group 1 (CK SRS Boost Therapy)"},{"description":"Radiation : CyberKnife® stereotactic radiosurgery salvage therapy (5 fractions) 3 times weekly.\n\nstereotactic radiosurgery: Given in 2 fractionated doses or 5 fractionated doses","id":"FG001","title":"Group 2 (CK SRS Salvage Therapy)"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}],"type":"Disease Progression"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"10"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"10"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"One subject that was enrolled onto the Boost Arm was withdrawn prior to undergoing cyberknife therapy due to disease progression.","recruitmentDetails":"Participants were recruited from within the investigators clinic practice between February 2009 and August 2013"}